Clinical Trial Update: Stellate Ganglion Blockade in Post-Menopausal Women [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating stellate ganglion blockade for vasomotor symptoms in postmenopausal women has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Vasomotor Symptoms

Snippet

Sponsor: Northwestern University | Conditions: Hot Flashes, Hot Flushes | Phase 2 | Status: WITHDRAWN